Timeliness-incentive home health management for metabolic dysfunction-associated steatotic liver disease

Table 2 Baseline patient characteristics and fatty liver severity, n (%)/mean ± SD/median (P25, P75)

Item	Total (n = 108)	Experimental group (n = 54)	Control group (n = 54)	χ2/t/Z	P value
Age (years)	42 (37, 52)	46 (40, 53)	44 (38, 49)	-1.172	0.242
Male	68 (63)	33 (61.1)	35 (64.8)	0.163	0.690
Smoking	26 (24.1)	12 (22.2)	14 (25.9)	0.203	0.653
Hypertension	15 (13.9)	10 (18.5)	5 (9.3)	1.943	0.164
Systolic blood pressure (mmHg)	127 (113, 134)	131 (118, 142)	120 (111, 129)	-2.722	0.006
Diastolic blood pressure (mmHg)	75 (69, 85)	81 ± 12	74 ± 10	3.292	0.001
Abdominal circumference (cm)	89 (82, 95)	90.02 ± 11.72	87.57 ± 8.35	1.252	0.215
BMI (kg/m2)	27 (24.56, 28.9)	27.72 ± 5.17	26.5 ± 1.85	1.532	0.130
Fasting blood glucose	5.27 (4.79, 5.74)	5.34 (4.94, 5.81)	5.21 (4.67, 5.57)	-1.542	0.124
AST (U/L)	25 (20, 30)	32 (23, 50)	27 (20, 43)	-1.392	0.165
ALT (U/L)	30 (22, 45)	26 (22, 32)	24 (19, 28)	-1.922	0.055
TG (mmol/L)	1.94 (1.38, 2.71)	2.04 (1.43, 2.67)	1.85 (1.28, 2.85)	-0.502	0.617
TC (mmol/L)	5.06 ± 0.93	5.24 ± 0.93	5.05 ± 0.78	1.121	0.266
LDL-C (mmol/L)	3.02 ± 0.71	3.10 ± 0.72	2.94 ± 0.70	1.151	0.250
HDL-C (mmol/L)	1.2 ± 0.23	1.19 ± 0.16	1.16 ± 0.22	0.731	0.469
Fatty liver grading				-0.803	0.426
Mild	32 (29.6)	18 (33.3)	14 (25.9)
Moderate	63 (58.4)	30 (55.6)	33 (61.1)
Severe	13 (12)	6 (11.1)	7 (13)
Total sample size				-0.953	0.341
Primary school and below	20 (18.5)	11 (20.4)	9 (16.7)
Junior high school	47 (43.5)	25 (46.3)	22 (40.7)
University and above	41 (38)	18 (33.3)	23 (42.6)

¹Data checked with the Student’s t test.

²Data checked with the Mann-Whitney U test.

³Data checked with the χ² test.

BMI: Body mass index; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; TG: Total triglyceride; TC: Total cholesterol; LDL-C: Low-density lipoprotein cholesterol; HDL-C: High-density lipoprotein cholesterol.